BNTX - Hot Stocks: PFE boosts travel retail; competing COVID stocks fall; SHAK rallies; CGC hits low

Friday's standout performers were largely defined by their relationship to Pfizer. The drug maker announced blockbuster results from a clinical trial of its COVID pill, revealing an 89% reduction in risk for hospitalization or death. In response, travel stocks rallied, including substantial gains in Delta (NYSE:DAL), United Airlines (NASDAQ:UAL), Southwest (NYSE:LUV), American Airlines (NASDAQ:AAL), Royal Caribbean (NYSE:RCL), Norwegian Cruise Line (NYSE:NCLH) and Carnival (NYSE:CCL). Meanwhile, the efficacy data contributed to an extension of a recent rally in retail stocks. This helped send Macy's (NYSE:M) and Dillard's (NYSE:DDS) to new 52-week highs. Not all the fallout from the PFE news led to a positive impact. Other companies working on anti-COVID options suddenly saw their products potentially eclipsed by the new drug. As a result, Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), BioNTech (NASDAQ:BNTX) and Merck (NYSE:MRK) all got slammed. Even with the outsized PFE influence, there was activity on Friday that had little to

For further details see:

Hot Stocks: PFE boosts travel, retail; competing COVID stocks fall; SHAK rallies; CGC hits low